At the end of June, more than 200,000 Canadians were registered to buy medical marijuana from more than 60 licensed Canadian producers.
TORONTO, ON–(Marketwired – September 25, 2017) – HydRx Farms Ltd. (o/a Scientus Pharma) (“Scientus Pharma“) is pleased to announce that... View Article
Innovative extraction process opens door to future cannabinoid based medical products LEAMINGTON, ON, Aug. 15, 2017 /CNW/ – Aphria Inc.... View Article
VANCOUVER, BC–(Marketwired – August 01, 2017) – Aequus Pharmaceuticals Inc., (“Aequus”) (TSX VENTURE: AQS) (OTCQB: AQSZF), a specialty life sciences company focused on... View Article
Click the link below for the full article. http://www.biotuesdays.com
For more of the story on developing the Scientus brand, see the case study at Method Branding.
Agreement to generate approximately $5 million in revenue for Aphria over 12-month contract LEAMINGTON, ONTARIO--(Marketwired - July 4, 2017) - Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF), through its subsidiary Pure Natures Wellness Inc.
Scientus Pharma will be at O’Cannabiz as a Gold Sponsor. The Expo is being held on Saturday April 22nd and Sunday April 23rd at the Sheraton Centre Toronto Hotel.
It happened by chance. Two scientists working on two entirely different lab projects at UHN (University Health Network) in Toronto discover each other’s work, only to find they share much in common. That simple introduction sparked a chain reaction that brings us to where we are today.
TORONTO, ON—(Marketwired – March 13, 2017) – HydRx Farms Ltd. (“HydRx“) and CannScience Innovations Inc. (“CannScience“) are pleased to announce that they have executed a definitive share exchange transaction pursuant to which HydRx has acquired all the issued and outstanding shares of CannScience in exchange for HydRx treasury shares.